DRSN Coordination Center

The NCI Drug Resistance and Sensitivity Network (DRSN) was developed to conduct preclinical research focused on innovative strategies to understand and combat mechanisms of tumor resistance (intrinsic or acquired) and/or to exploit tumor sensitivity to anti-cancer therapies

The DRSN Coordinating Center (U24) will support, facilitate and integrate ongoing and future collaborative activities among the DRSN-funded components. The DRSN Coordinating Center will also promote scientific outreach and research integration with other Cancer Moonshot initiatives and the larger scientific community.